The compromise of the respiratory and digestive system in patients infected with the new emerging coronavirus becomes apparent. However, there may also be compromise of other important systems, such as the kidney system. It is essential that the clinician does not forget that renal patients often concomit with cardiovascular diseases, since in both pathologies the prognosis of infected-contagious disease caused by the nobel coronavirus becomes bleak. There are still no effective and approved drugs to deal with this virus. Today, the possible beneficial effect of antimalarials (hydroxychloroquine and chloroquine) in the treatment of patients infected with the virus is presumed. It is hoped that through the antiviral properties exhibited by these drugs, the prognosis and mortality associated with this disease will be improved. To this end, a considerable number of trials are advanced that scrutinize and discuss its usefulness in the pathology of current interest.